Literature DB >> 14652809

Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma.

Brigitte Franc1, Pauline de la Salmonière, Françoise Lange, Catherine Hoang, Albert Louvel, Anne de Roquancourt, Françoise Vildé, Gilles Hejblum, Sylvie Chevret, Claude Chastang.   

Abstract

We evaluated the interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma (FTC). Forty-one anonymous FTC pathology slides were independently reviewed by 5 pathologists, and 31 of them were also evaluated twice by the same pathologist. A final consensus diagnosis (FCD) was made at the end of the study. Interobserver and intraobserver agreement was determined as the kappa statistic for qualitative data and intraclass correlation coefficient for quantitative data. The agreement between the 5 observers' initial diagnosis and the FCD was 0.69, 0.41, 0.35, 0.28 and 0.11, respectively, strongly suggesting a leadership phenomenon. The FCD classified 30 cases as malignant, including 24 cases diagnosed as FTC. There was unanimous agreement about 13 of the 24 FTCs. Diagnostic reproducibility was found to be acceptable for the nonminimally invasive FTC. Diagnostic discrepancies occurred in 57% of the seven cases classified as minimally invasive FTC by the FCD. FCD excluded malignancy in 11 cases including 6 atypical adenomas. Interobserver and intraobserver agreement for FTC diagnosis was 0.23 (standard error [SE], 0.04) and 0.68, respectively. Interobserver and intraobserver agreement for the presence of vascular invasion was 0.20 (SE, 0.04) and 0.51, respectively, contrasting with a moderate to substantial level of agreement when considering the number of vascular invasion. Interobserver and intraobserver agreement for nucleus optical clearing were slight and moderate, respectively. The importance of the study is the confirmation that diagnostic reproducibility of minimally invasive FTC is low and that this has clinical implications, and also implications for the design of studies into the treatment and outcome of FTC.

Entities:  

Mesh:

Year:  2003        PMID: 14652809     DOI: 10.1016/s0046-8177(03)00403-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  37 in total

1.  [Benign thyroid nodule or thyroid cancer?].

Authors:  D Führer; K W Schmid
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

Review 2.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions.

Authors:  Carrie C Lubitz; Stacy K Ugras; J Jacob Kazam; Biaxin Zhu; Theresa Scognamiglio; Yao-Tseng Chen; Thomas J Fahey
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

4.  How to combine ultrasound and cytological information in decision making about thyroid nodules.

Authors:  Jin Young Kwak; Eun-Kyung Kim; Hye Jung Kim; Min Jung Kim; Eun Ju Son; Hee Jung Moon
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

5.  European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics.

Authors:  Ralf Paschke; Silvia Cantara; Anna Crescenzi; Barbara Jarzab; Thomas J Musholt; Manuel Sobrinho Simoes
Journal:  Eur Thyroid J       Date:  2017-05-19

Review 6.  Molecular profiling of thyroid nodule fine-needle aspiration cytology.

Authors:  Markus Eszlinger; Lorraine Lau; Sana Ghaznavi; Christopher Symonds; Shamir P Chandarana; Moosa Khalil; Ralf Paschke
Journal:  Nat Rev Endocrinol       Date:  2017-03-31       Impact factor: 43.330

7.  Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.

Authors:  Krzysztof Glomski; Vania Nosé; William C Faquin; Peter M Sadow
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

8.  Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.

Authors:  Lamya Rezig; Adele Servadio; Liborio Torregrossa; Paolo Miccoli; Fulvio Basolo; Laetitia Shintu; Stefano Caldarelli
Journal:  Metabolomics       Date:  2018-10-10       Impact factor: 4.290

9.  NDRG1 protein overexpression in malignant thyroid neoplasms.

Authors:  Renê Gerhard; Suely Nonogaki; José Humberto Tavares Guerreiro Fregnani; Fernando Augusto Soares; Maria Aparecida Nagai
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

10.  Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.

Authors:  Jean-Fred Fontaine; Delphine Mirebeau-Prunier; Mahatsangy Raharijaona; Brigitte Franc; Stephane Triau; Patrice Rodien; Olivier Goëau-Brissonniére; Lucie Karayan-Tapon; Marielle Mello; Rémi Houlgatte; Yves Malthiery; Frédérique Savagner
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.